Dashboard
1
Flat results in Jun 25
- INTEREST(HY) At CHF 0.17 MM has Grown at 23.24%
- DEBT-EQUITY RATIO (HY) Highest at 2.33 %
- CASH AND EQV(HY) Lowest at CHF 29.14 MM
2
With ROE of 7.81%, it has a Very Expensive valuation with a 3.03 Price to Book Value
3
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.51%
0%
-13.51%
6 Months
-2.66%
0%
-2.66%
1 Year
-19.1%
0%
-19.1%
2 Years
-17.21%
0%
-17.21%
3 Years
-39.91%
0%
-39.91%
4 Years
-91.6%
0%
-91.6%
5 Years
-85.24%
0%
-85.24%
Bachem Holding AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.73%
EBIT Growth (5y)
16.17%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.14
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.50
Tax Ratio
11.07%
Dividend Payout Ratio
53.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.44%
ROE (avg)
10.17%
Valuation key factors
Factor
Value
P/E Ratio
39
Industry P/E
Price to Book Value
3.03
EV to EBIT
25.37
EV to EBITDA
20.45
EV to Capital Employed
2.98
EV to Sales
6.12
PEG Ratio
NA
Dividend Yield
154.83%
ROCE (Latest)
11.75%
ROE (Latest)
7.81%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
577.30
531.70
8.58%
Operating Profit (PBDIT) excl Other Income
165.90
159.60
3.95%
Interest
0.40
0.70
-42.86%
Exceptional Items
3.60
0.00
Consolidate Net Profit
111.90
100.70
11.12%
Operating Profit Margin (Excl OI)
222.70%
237.50%
-1.48%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 8.58% vs 5.66% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 11.12% vs -12.21% in Dec 2022
About Bachem Holding AG 
Bachem Holding AG
Pharmaceuticals & Biotechnology
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Company Coordinates 
Company Details
Hauptstrasse 144 , BUBENDORF None : 4416
Registrar Details






